|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zuo TT, Zheng RS, Zhang SW, Zeng HM and
Chen WQ: Incidence and mortality of liver cancer in China in 2011.
Chin J Cancer. 34:562015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tanaka M, Katayama F, Kato H, Tanaka H,
Wang J, Qiao YL and Inoue M: Hepatitis B and C virus infection and
hepatocellular carcinoma in China: A review of epidemiology and
control measures. J Epidemiol. 21:401–416. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Panayiotidis MI: Cancer epigenetics as
biomarkers of clinical significance. Cancer Lett. 342:168–169.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Udali S, Guarini P, Moruzzi S, Ruzzenente
A, Tammen SA, Guglielmi A, Conci S, Pattini P, Olivieri O,
Corrocher R, et al: Global DNA methylation and hydroxymethylation
differ in hepatocellular carcinoma and cholangiocarcinoma and
relate to survival rate. Hepatology. 62:496–504. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jones PA and Takai D: The role of DNA
methylation in mammalian epigenetics. Science. 293:1068–1070. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jain S, Xie L, Boldbaatar B, Lin SY,
Hamilton JP, Meltzer SJ, Chen SH, Hu CT, Block TM, Song W and Su
YH: Differential methylation of the promoter and first exon of the
RASSF1A gene in hepatocarcinogenesis. Hepatol Res. 45:110–123.
2015. View Article : Google Scholar
|
|
10
|
Hinrichsen I, Kemp M, Peveling-Oberhag J,
Passmann S, Plotz G, Zeuzem S and Brieger A: Promoter methylation
of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs.
PLoS One. 9:e844532014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu B, Nie Y, Liu X, Feng S, Yang Z, Wang
Z, Zheng Q and Luo X: Quantitative analysis of APC promoter
methylation in hepatocellular carcinoma and its prognostic
implications. Oncol Lett. 7:1683–1688. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jain S, Chen S, Chang KC, Lin YJ, Hu CT,
Boldbaatar B, Hamilton JP, Lin SY, Chang TT, Chen SH, et al: Impact
of the location of CpG methylation within the GSTP1 gene on its
specificity as a DNA marker for hepatocellular carcinoma. PLoS One.
7:e357892012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qu Z, Jiang Y, Li H, Yu DC and Ding YT:
Detecting abnormal methylation of tumor suppressor genes GSTP1,
P16, RIZ1, and RASSF1A in hepatocellular carcinoma and its clinical
significance. Oncol Lett. 10:2553–2558. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen J, Wang S, Zhang YJ, Wu HC, Kibriya
MG, Jasmine F, Ahsan H, Wu DP, Siegel AB, Remotti H and Santella
RM: Exploring genome-wide DNA methylation profiles altered in
hepatocellular carcinoma using Infinium HumanMethylation 450
BeadChips. Epigenetics. 8:34–43. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bibikova M, Barnes B, Tsan C, Ho V,
Klotzle B, Le JM, Delano D, Zhang L, Schroth GP, Gunderson KL, et
al: High density DNA methylation array with single CpG site
resolution. Genomics. 98:288–295. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Esteller M: Epigenetic gene silencing in
cancer: The DNA hypermethylome. Hum Mol Genet. 16:R50–R59. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Herman JG and Baylin SB: Gene silencing in
cancer in association with promoter hypermethylation. N Engl J Med.
349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yates DR, Rehman I, Meuth M, Cross SS,
Hamdy FC and Catto JW: Methylational urinalysis: A prospective
study of bladder cancer patients and age stratified benign
controls. Oncogene. 25:1984–1988. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dudziec E, Miah S, Choudhry HM, Owen HC,
Blizard S, Glover M, Hamdy FC and Catto JW: Hypermethylation of CpG
islands and shores around specific microRNAs and mirtrons is
associated with the phenotype and presence of bladder cancer. Clin
Cancer Res. 17:1287–1296. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Irizarry RA, Ladd-Acosta C, Wen B, Wu Z,
Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, et al:
The human colon cancer methylome shows similar hypo- and
hypermethylation at conserved tissue-specific CpG island shores.
Nat Genet. 41:178–186. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nishida N, Kudo M, Nagasaka T, Ikai I and
Goel A: Characteristic patterns of altered DNA methylation predict
emergence of human hepatocellular carcinoma. Hepatology.
56:994–1003. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shen J, Wang S, Zhang YJ, Kappil M, Wu HC,
Kibriya MG, Wang Q, Jasmine F, Ahsan H, Lee PH, et al: Genome-wide
DNA methylation profiles in hepatocellular carcinoma. Hepatology.
55:1799–1808. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Udali S, Guarini P, Ruzzenente A,
Ferrarini A, Guglielmi A, Lotto V, Tononi P, Pattini P, Moruzzi S,
Campagnaro T, et al: DNA methylation and gene expression profiles
show novel regulatory pathways in hepatocellular carcinoma. Clin
Epigenetics. 7:432015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao W, Kondo Y, Shen L, Shimizu Y, Sano T,
Yamao K, Natsume A, Goto Y, Ito M, Murakami H, et al: Variable DNA
methylation patterns associated with progression of disease in
hepatocellular carcinomas. Carcinogenesis. 29:1901–1910. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shin SH, Kim BH, Jang JJ, Suh KS and Kang
GH: Identification of novel methylation markers in hepatocellular
carcinoma using a methylation array. J Korean Med Sci.
25:1152–1159. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ammerpohl O, Pratschke J, Schafmayer C, et
al: Distinct DNA methylation patterns in cirrhotic liver and
hepatocellular carcinoma. Int J Cancer. 130:1319–1328. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kohles N, Nagel D, Jüngst D, Durner J,
Stieber P and Holdenrieder S: Prognostic relevance of oncological
serum biomarkers in liver cancer patients undergoing transarterial
chemoembolization therapy. Tumour Biol. 33:33–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Doi A, Park IH, Wen B, Murakami P, Aryee
MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, et al:
Differential methylation of tissue- and cancer-specific CpG island
shores distinguishes human induced pluripotent stem cells,
embryonic stem cells and fibroblasts. Nat Genet. 41:1350–1353.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ogoshi K, Hashimoto S, Nakatani Y, Qu W,
Oshima K, Tokunaga K, Sugano S, Hattori M, Morishita S and
Matsushima K: Genome-wide profiling of DNA methylation in human
cancer cells. Genomics. 98:280–287. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rakyan VK, Down TA, Balding DJ and Beck S:
Epigenome-wide association studies for common human diseases. Nat
Rev Genet. 12:529–541. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Weber M, Davies JJ, Wittig D, Oakeley EJ,
Haase M, Lam WL and Schübeler D: Chromosome-wide and
promoter-specific analyses identify sites of differential DNA
methylation in normal and transformed human cells. Nat Genet.
37:853–862. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Calvisi DF, Pascale RM and Feo F:
Dissection of signal transduction pathways as a tool for the
development of targeted therapies of hepatocellular carcinoma. Rev
Recent Clin Trials. 2:217–236. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kuo KK, Jian SF, Li YJ, Wan SW, Weng CC,
Fang K, Wu DC and Cheng KH: Epigenetic inactivation of transforming
growth factor-beta1 target gene HEYL, a novel tumor suppressor, is
involved in the P53-induced apoptotic pathway in hepatocellular
carcinoma. Hepatol Res. 45:782–793. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Umer M, Qureshi SA, Hashmi ZY, Raza A,
Ahmad J, Rahman M and Iqbal M: Promoter hypermethylation of Wnt
pathway inhibitors in hepatitis C virus-induced multistep
hepatocarcinogenesis. Virol J. 11:1172014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ding SL, Yang ZW, Wang J, Zhang XL, Chen
XM and Lu FM: Integrative analysis of aberrant Wnt signaling in
hepatitis B virus-related hepatocellular carcinoma. World J
Gastroenterol. 21:6317–6328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stefanska B, Cheishvili D, Suderman M,
Arakelian A, Huang J, Hallett M, Han ZG, Al-Mahtab M, Akbar SM,
Khan WA, et al: Genome-wide study of hypomethylated and induced
genes in patients with liver cancer unravels novel anticancer
targets. Clin Cancer Res. 20:3118–3132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yan W, Herman JG and Guo M:
Epigenome-based personalized medicine in human cancer. Epigenomics.
8:119–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ghoshal K and Bai S: DNA
methyltransferases as targets for cancer therapy. Drugs Today
(Barc). 43:395–422. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yoo CB, Jeong S, Egger G, Liang G,
Phiasivongsa P, Tang C, Redkar S and Jones PA: Delivery of
5-aza-2′-deoxycytidine to cells using oligodeoxynucleotides. Cancer
Res. 67:6400–6408. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Datta J, Ghoshal K, Denny WA, Gamage SA,
Brooke DG, Phiasivongsa P, Redkar S and Jacob ST: A new class of
quinoline-based DNA hypomethylating agents reactivates tumor
suppressor genes by blocking DNA methyltransferase 1 activity and
inducing its degradation. Cancer Res. 69:4277–4285. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gros C, Fleury L, Nahoum V, Faux C,
Valente S, Labella D, Cantagrel F, Rilova E, Bouhlel MA,
David-Cordonnier MH, et al: New insights on the mechanism of
quinoline-based DNA Methyltransferase inhibitors. J Biol Chem.
290:6293–6302. 2015. View Article : Google Scholar : PubMed/NCBI
|
